IDEAS home Printed from https://ideas.repec.org/p/zbw/ifwkie/273506.html
   My bibliography  Save this paper

Exploring the clinical benefit of ventilation therapy across various patient groups with COVID-19 using real-world data

Author

Listed:
  • Abbasi-Kangevari, Mohsen
  • Ghanbari, Ali
  • Malekpour, Mohammad-Reza
  • Ghamari, Seyyed-Hadi
  • Azadnajafabad, Sina
  • Saeedi Moghaddam, Sahar
  • Keykhaei, Mohammad
  • Haghshenas, Rosa
  • Golestani, Ali
  • Rashidi, Mohammad-Mahdi
  • Rezaei, Nazila
  • Ghasemi, Erfan
  • Rezaei, Negar
  • Jamshidi, Hamid Reza
  • Larijani, Bagher

Abstract

Scarcity of ventilators during COVID-19 pandemic has urged public health authorities to develop prioritization recommendations and guidelines with the real-time decision-making process based on the resources and contexts. Nevertheless, patients with COVID-19 who will benefit the most from ventilation therapy have not been well-defined yet. Thus, the objective of this study was to investigate the benefit of ventilation therapy among various patient groups with COVID-19 admitted to hospitals, based on the real-world data of hospitalized adult patients. Data used in the longitudinal study included 599,340 records of hospitalized patients who were admitted from February 2020 to June 2021. All participants were categorized based on sex, age, city of residence, the hospitals' affiliated university, and their date of hospitalization. Age groups were defined as 18–39, 40–64, and more than 65-year-old participants. Two models were used in this study: in the first model, participants were assessed by their probability of receiving ventilation therapy during hospitalization based on demographic and clinical factors using mixed-effects logistic regression. In the second model, the clinical benefit of receiving ventilation therapy among various patient groups was quantified while considering the probability of receiving ventilation therapy during hospital admission, as estimated in the first model. The interaction coefficient in the second model indicated the difference in the slope of the logit probability of recovery for a one-unit increase in the probability of receiving ventilation therapy between the patients who received ventilation compared to those who did not while considering other factors constant. The interaction coefficient was used as an indicator to quantify the benefit of ventilation reception and possibly be used as a criterion for comparison among various patient groups. Among participants, 60,113 (10.0%) cases received ventilation therapy, 85,158 (14.2%) passed away due to COVID-19, and 514,182 (85.8%) recovered. The mean (SD) age was 58.5 (18.3) [range = 18–114, being 58.3 (18.2) among women, and 58.6 (18.4) among men]. Among all groups with sufficient data for analysis, patients aged 40–64 years who had chronic respiratory diseases (CRD) and malignancy benefitted the most from ventilation therapy; followed by patients aged 65 + years who had malignancy, cardiovascular diseases (CVD), and diabetes (DM); and patients aged 18–39 years who had malignancy. Patients aged 65 + who had CRD and CVD gained the least benefit from ventilation therapy. Among patients with DM, patients aged 65 + years benefited from ventilation therapy, followed by 40–64 years. Among patients with CVD, patients aged 18–39 years benefited the most from ventilation therapy, followed by patients aged 40–64 years and 65 + years. Among patients with DM and CVD, patients aged 40–64 years benefited from ventilation therapy, followed by 65 + years. Among patients with no history of CRD, malignancy, CVD, or DM, patients aged 18–39 years benefited the most from ventilation therapy, followed by patients aged 40–64 years and 65 + years. This study promotes a new aspect of treating patients for ventilators as a scarce medical resource, considering whether ventilation therapy would improve the patient's clinical outcome. Should the prioritization guidelines for ventilators allocation take no notice of the real-world data, patients might end up being deprived of ventilation therapy, who could benefit the most from it. It could be suggested that rather than focusing on the scarcity of ventilators, guidelines focus on evidence-based decision-making algorithms to also take the usefulness of the intervention into account, whose beneficial effect is dependent on the selection of the right time in the right patient.

Suggested Citation

  • Abbasi-Kangevari, Mohsen & Ghanbari, Ali & Malekpour, Mohammad-Reza & Ghamari, Seyyed-Hadi & Azadnajafabad, Sina & Saeedi Moghaddam, Sahar & Keykhaei, Mohammad & Haghshenas, Rosa & Golestani, Ali & Ra, 2023. "Exploring the clinical benefit of ventilation therapy across various patient groups with COVID-19 using real-world data," Open Access Publications from Kiel Institute for the World Economy 273506, Kiel Institute for the World Economy (IfW Kiel).
  • Handle: RePEc:zbw:ifwkie:273506
    DOI: 10.1038/s41598-023-37912-5
    as

    Download full text from publisher

    File URL: https://www.econstor.eu/bitstream/10419/273506/1/s41598-023-37912-5.pdf
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41598-023-37912-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Michael C Grant & Luke Geoghegan & Marc Arbyn & Zakaria Mohammed & Luke McGuinness & Emily L Clarke & Ryckie G Wade, 2020. "The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries," PLOS ONE, Public Library of Science, vol. 15(6), pages 1-19, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Najeeb Ullah & Khurshid Ahmad Khan & Javeid Iqbal & Asim Rana & Bilal Bin Younis & Mohsin Asif & Aijaz Zeeshan Khan Chachar & Falak shan, 2020. "Efficacy of Remdesivir in Covid-19 Patients; Multicenter Study in Lahore," International Journal of Sciences, Office ijSciences, vol. 9(11), pages 31-34, November.
    2. Oliver Viera-Segura & Natali Vega-Magaña & Mariel García-Chagollán & Marcela Peña-Rodríguez & Germán Muñoz-Sánchez & Ahtziri Socorro Carranza-Aranda & Iris Monserrat Llamas-Covarrubias & Moisés Ramos-, 2021. "A Comprehensive Descriptive Epidemiological and Clinical Analysis of SARS-CoV-2 in West-Mexico during COVID-19 Pandemic 2020," IJERPH, MDPI, vol. 18(20), pages 1-13, October.
    3. Caterina Alacevich & Inna Thalmann & Catia Nicodemo & Simon Lusignan & Stavros Petrou, 2023. "Symptomatic SARS-CoV-2 Episodes and Health-Related Quality of Life," Applied Health Economics and Health Policy, Springer, vol. 21(5), pages 761-771, September.
    4. Matthew Whitaker & Joshua Elliott & Barbara Bodinier & Wendy Barclay & Helen Ward & Graham Cooke & Christl A. Donnelly & Marc Chadeau-Hyam & Paul Elliott, 2022. "Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    5. Bo Zhao & Fanlei Kong & Myo Nyein Aung & Motoyuki Yuasa & Eun Woo Nam, 2020. "Novel Coronavirus (COVID-19) Knowledge, Precaution Practice, and Associated Depression Symptoms among University Students in Korea, China, and Japan," IJERPH, MDPI, vol. 17(18), pages 1-17, September.
    6. Yuen, Kum Fai & Cai, Lanhui & Wee, Shaun Chuin Kit & Wang, Xueqin, 2024. "Pandemic-driven acceptance of urban drone deliveries," Transport Policy, Elsevier, vol. 146(C), pages 356-370.
    7. Nikola Anđelić & Sandi Baressi Šegota & Ivan Lorencin & Zdravko Jurilj & Tijana Šušteršič & Anđela Blagojević & Alen Protić & Tomislav Ćabov & Nenad Filipović & Zlatan Car, 2021. "Estimation of COVID-19 Epidemiology Curve of the United States Using Genetic Programming Algorithm," IJERPH, MDPI, vol. 18(3), pages 1-26, January.
    8. Carol Nash, 2020. "Report on Digital Literacy in Academic Meetings during the 2020 COVID-19 Lockdown," Challenges, MDPI, vol. 11(2), pages 1-24, September.
    9. Nguyen, My, 2020. "Mask Mandates and COVID-19 Related Symptoms in the US," MPRA Paper 109992, University Library of Munich, Germany.
    10. Laurent Gerbaud & Candy Guiguet-Auclair & Franck Breysse & Joséphine Odoul & Lemlih Ouchchane & Jonathan Peterschmitt & Camille Dezfouli-Desfer & Vincent Breton, 2020. "Hospital and Population-Based Evidence for COVID-19 Early Circulation in the East of France," IJERPH, MDPI, vol. 17(19), pages 1-17, September.
    11. Erika Christina Gouveia e Silva & Ana Carolina Basso Schmitt & Caroline Gil de Godoy & Danielle Brancolini de Oliveira & Clarice Tanaka & Carlos Toufen & Carlos Roberto Ribeiro de Carvalho & Celso R. , 2023. "Risk Factors for the Impairment of Ambulation in Older People Hospitalized with COVID-19: A Retrospective Cohort Study," IJERPH, MDPI, vol. 20(22), pages 1-10, November.
    12. Arthur Eumann Mesas & Iván Cavero-Redondo & Celia Álvarez-Bueno & Marcos Aparecido Sarriá Cabrera & Selma Maffei de Andrade & Irene Sequí-Dominguez & Vicente Martínez-Vizcaíno, 2020. "Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-23, November.
    13. Marcin Januszewski & Laura Ziuzia-Januszewska & Alicja A. Jakimiuk & Waldemar Wierzba & Anna Gluszko & Joanna Zytynska-Daniluk & Artur J. Jakimiuk, 2021. "Is the Course of COVID-19 Different during Pregnancy? A Retrospective Comparative Study," IJERPH, MDPI, vol. 18(22), pages 1-15, November.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:zbw:ifwkie:273506. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ZBW - Leibniz Information Centre for Economics (email available below). General contact details of provider: https://edirc.repec.org/data/iwkiede.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.